🇺🇸 FDA

Company profile · Sponsor

BriaCell

BriaCell Therapeutics

BCTX · NYSE pharma WEST VANCOUVER, A1, USA
Pipeline
3
Drugs
0
Patents
1

Quick answer

BriaCell (BCTX) is a pharma company. headquartered in WEST VANCOUVER, A1, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 1 patent to this profile..

Company facts

Ticker BCTX
Exchange NYSE
Company type pharma
Headquarters WEST VANCOUVER, A1, USA
SEC CIK 0001610820

Pipeline (3)

Search pipeline →

  1. SV-BR-1-GM

    BriaCell

    Breast Cancer

    phase 3 mab active

    2 trials

  2. BC1 cell line

    BriaCell

    Breast Cancer

    phase 2 mab active

    1 trial

  3. SV-BR-1-GM

    BriaCell

    Breastcancer

    phase 2 mab completed

    1 trial

Patents (1)

Search patents →

  1. US 11559574

    Whole-cell cancer vaccines and methods for selection thereof

    Expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is BriaCell?

BriaCell (BCTX) is a pharma company. headquartered in WEST VANCOUVER, A1, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 1 patent to this profile..

What pipeline programs does BriaCell sponsor?

We track 3 ClinicalTrials.gov-linked programs for BriaCell, including SV-BR-1-GM and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does BriaCell company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.